Full Text
Systematic Review of the Cost Effectiveness of Dapagliflozin Used to Treat Patients with Type 2 Diabetes Mellitus

Abstract

Authors

J Tsan T Duong N Girgis M Labib A Moustakas FE Loh

Back to Volume 21, Supplemental S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×